We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology

2023 Volume 3 Issue 2

Designing Dereplication Before Isolation: A Decision Architecture for Combining LC–HRMS, MS/MS Similarity, NMR Evidence, and Taxonomic Context in Natural-Product Discovery


, ,
  1. Department of Dereplication and Analytical Strategy, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
  2. Department of LC–HRMS and NMR Integration, Graduate School of Pharmacy, Kyoto University, Kyoto, Japan.
Abstract

Dereplication is often described as the recognition of known natural products before resources are committed to repeated isolation and structure elucidation. In contemporary discovery, however, consequential decisions are increasingly made while chemical identity remains incomplete. LC–HRMS features, molecular formulas, MS/MS similarities, predicted compound classes, ranked structural candidates, mixture-level NMR evidence, and taxonomic occurrence each provide different forms of information, with different dependencies and failure modes. This article develops an original methodological decision architecture for using such evidence before full isolation without converting provisional inference into premature identification. The central proposal is to treat dereplication as an action-guiding process in which evidence is retained at its native analytical resolution, dependencies among evidence sources are made explicit, and contextual information modifies rather than substitutes for structural evidence. The architecture distinguishes analyte consolidation from annotation, relational similarity from identity, candidate generation from validation, and taxonomic plausibility from direct chemical observation. It further separates decisions about whether to deprioritize, re-interrogate, enrich, isolate, or escalate a feature from claims that its structure has been established. The framework is intended to improve transparency and resource allocation rather than provide a universal scoring rule. Its principal limitations are the incompleteness of spectral and occurrence databases, metric-dependent similarity, isomeric and stereochemical ambiguity, mixture complexity, correlated computational evidence, and variable taxonomic expression. Prospective testing against independently established structures will be required before claims of decision superiority are justified.


How to cite this article
Vancouver
Tanaka K, Kobayashi Y, Nakamura T. Designing Dereplication Before Isolation: A Decision Architecture for Combining LC–HRMS, MS/MS Similarity, NMR Evidence, and Taxonomic Context in Natural-Product Discovery. Spec J Pharmacogn Phytochem Biotechnol. 2023;3(2):31-40. https://doi.org/10.51847/kezMDOqZta
APA
Tanaka, K., Kobayashi, Y., & Nakamura, T. (2023). Designing Dereplication Before Isolation: A Decision Architecture for Combining LC–HRMS, MS/MS Similarity, NMR Evidence, and Taxonomic Context in Natural-Product Discovery. Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology, 3(2), 31-40. https://doi.org/10.51847/kezMDOqZta

About GalaxyPub

Find out more

Established in 2019, Galaxy Publication stands as a global academic publishing house focused on advancing scholarly work across medicine, nursing, and health sciences. Through its network of peer-reviewed journals, the organization brings together original research and academic contributions from scholars around the world, creating a shared space for knowledge exchange and intellectual collaboration.